Gary Ruvkun | |
---|---|
Born | [1] Berkeley, California, U.S.[2] | March 26, 1952
Alma mater | University of California, Berkeley (BA) Harvard University (PhD) |
Awards | |
Scientific career | |
Institutions | University of California, Berkeley Harvard University Massachusetts Institute of Technology Massachusetts General Hospital |
Thesis | The molecular genetic analysis of symbiotic nitrogen fixation (NIF) genes from rhizobium meliloti (1982) |
Doctoral advisor | Frederick Ausubel |
Website | ruvkun |
Gary Bruce Ruvkun (born March 26, 1952) is an American molecular biologist and Nobel laureate at Massachusetts General Hospital and professor of genetics at Harvard Medical School in Boston.[3]
Ruvkun discovered the mechanism by which lin-4, the first microRNA (miRNA) discovered by Victor Ambros, regulates the translation of target messenger RNAs via imperfect base-pairing to those targets, and discovered the second miRNA, let-7, and that it is conserved across animal phylogeny, including in humans. These miRNA discoveries revealed a new world of RNA regulation at an unprecedented small size scale, and the mechanism of that regulation. Ruvkun also discovered many features of insulin-like signaling in the regulation of aging and metabolism.
He was elected a Member of the American Philosophical Society in 2019. Ruvkun was awarded the 2024 Nobel Prize in Physiology or Medicine for the discovery of microRNA and its role in post-transcriptional gene regulation.[4]